Evolute Bioscience Ends Animal Testing in Pharmacology Education
In a significant move for ethical education, Evolute Bioscience, a biotechnology firm based in Trichy, Tamil Nadu, has signed a formal agreement to permanently cease all experiments on animals in its pharmacology programs. This decision marks a shift from traditional methods that previously required animal testing in undergraduate and postgraduate classes.
Partnership with Peta India and Simcology
The transition to cruelty-free education is facilitated by a partnership with People for the Ethical Treatment of Animals (Peta) India and Himachal Pradesh-based simulation developer Simcology India. Peta has provided Evolute Bioscience with Simcology's interactive virtual simulation software free of cost. This software enables pharmacology students to conduct experiments using computer-assisted learning methods, eliminating the need for live animal subjects.
Discussions with Peta highlighted the superiority of non-animal research and education techniques, prompting the firm's decision. The software allows for repeated use, saving time and money while maintaining ecological balance by sparing animal lives.
Details of the Agreement
As per the agreement, Evolute Bioscience has permanently prohibited the use of living and deceased animals, as well as animal parts, in all aspects of its pharmacology education. This includes teaching, training, demonstrations, research, and thesis work at both undergraduate and postgraduate levels.
Additionally, the firm has cancelled plans to procure at least 50 mice annually for a new educational stream focused on disease model-related animal testing. It will also discontinue using 60 zebra fish for experimentation purposes. The transition to non-animal methods will be completed once the simulation module from Simcology is finalized.
Statements from Key Figures
Anjana Aggarwal, Peta India scientist and research policy advisor, emphasized the importance of modern tools in education. "Pharmacology students deserve the best training possible, and that means using modern simulation tools instead of mutilating and killing animals in cruel and outdated experiments," she said. "Mice and other animals are not relevant to human pharmacology education, and Peta encourages all pharmacology programmes to follow the progressive decision by Evolute Bioscience to advance student education while sparing animals' lives."
Preyenga Saravanan, managing director of Evolute Bioscience, expressed gratitude for the donation. "Evolute Bioscience greatly appreciates Peta India for donating Simcology software that allows us to replace our experiments on animals in our undergraduate and postgraduate educational curricula while also enhancing the quality of learning for our students," he stated.
Broader Context and Impact
This move aligns with broader trends in medical education. In 2022, following recommendations from Peta, the National Medical Commission revised its guidelines for postgraduate pharmacology curricula. The new guidelines recommend the use of several non-animal teaching and training methods and no longer make certain routine laboratory experiments on animals mandatory.
Research indicates that many students at various educational levels are uncomfortable with animal use in dissection and experimentation. Some even avoid scientific careers to uphold their ethical principles. The adoption of virtual simulations addresses these concerns, offering a humane alternative that does not compromise educational quality.
By ending animal testing, Evolute Bioscience sets a precedent for other institutions, promoting a future where pharmacology education can be both effective and ethical, saving countless animal lives in the process.
